SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tnsaf10/19/2013 9:30:37 PM
   of 7143
 
A quorum-sensing inhibitor blocks Pseudomonas aeruginosavirulence and biofilm formation
Colleen T. O’Loughlin a, Laura C. Miller b, Albert Siryaporn a, Knut Drescher a, c, Martin F. Semmelhack b, and Bonnie L. Bassler a, d, 1 Author Affiliations

Contributed by Bonnie L. Bassler, September 18, 2013 (sent for review July 23, 2013)

Significance
In this study, we prepare synthetic molecules and analyze them for inhibition of the Pseudomonasquorum-sensing receptors LasR and RhlR. Our most effective compound, meta-bromo-thiolactone, not only prevents virulence factor expression and biofilm formation but also protects Caenorhabditis elegans and human A549 lung epithelial cells from quorum-sensing–mediated killing byPseudomonas aeruginosa. This anti–quorum-sensing molecule is capable of influencing P. aeruginosa virulence in tissue culture and animal models. Our findings demonstrate the potential for small-molecule modulators of quorum sensing as therapeutics.

Abstract
Quorum sensing is a chemical communication process that bacteria use to regulate collective behaviors. Disabling quorum-sensing circuits with small molecules has been proposed as a potential strategy to prevent bacterial pathogenicity. The human pathogen Pseudomonas aeruginosa uses quorum sensing to control virulence and biofilm formation. Here, we analyze synthetic molecules for inhibition of the two P. aeruginosa quorum-sensing receptors, LasR and RhlR. Our most effective compound, meta-bromo-thiolactone (mBTL), inhibits both the production of the virulence factor pyocyanin and biofilm formation. mBTL also protects Caenorhabditis elegans and human lung epithelial cells from killing by P. aeruginosa. Both LasR and RhlR are partially inhibited by mBTL in vivo and in vitro; however, RhlR, not LasR, is the relevant in vivo target. More potent antagonists do not exhibit superior function in impeding virulence. Because LasR and RhlR reciprocally control crucial virulence factors, appropriately tuning rather than completely inhibiting their activities appears to hold the key to blocking pathogenesis in vivo.

Link to the Open Source article
pnas.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext